Krieger Deborah, Hansen Keith, McDermott Colleen, Matthews Roy, Mitchell Rachel, Bollegala Natasha, Bhalerao Shree
University of Alberta Medical School, Edmonton, Alberta, Canada.
NeuroRehabilitation. 2003;18(3):205-8.
The use of typical neuroleptics has always been the mainstay of treatment for delirium following traumatic brain injury (TBI). Given the recent application of atypical neuroleptics to various psychiatric conditions formerly treated with typical neuroleptics, one questions whether this new class of drugs is superior to its predecessor in treating delirium post-TBI. We present a case of one patient with TBI-induced delirium where in fact the use of the typical mid-potency neuroleptic, loxapine, appeared to have a better clinical effect over the atypical neuroleptic, olanzapine.
使用典型抗精神病药物一直是治疗创伤性脑损伤(TBI)后谵妄的主要方法。鉴于最近非典型抗精神病药物已应用于以前用典型抗精神病药物治疗的各种精神疾病,有人质疑这类新药在治疗TBI后谵妄方面是否优于其前身。我们报告一例TBI所致谵妄患者的病例,实际上,使用典型的中效抗精神病药物洛沙平似乎比非典型抗精神病药物奥氮平具有更好的临床效果。